Evidence map›Paper›PMID 9211978›Full record

ArticleChromosoma1997

Delocalization of some small nucleolar RNPs after actinomycin D treatment to deplete early pre-rRNAs.

R Rivera-León, S A Gerbi

Abstract read
PubMed Publisher
In one paragraph

Article in Chromosoma, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R Rivera-LeónBrown University, Division of Biology and Medicine, Department of Molecular Biology, Cell Biology and Biochemistry, Providence, RI 02912, USA.
S A Gerbi
Brown University · US

Funding

U3 SNRNA NUCLEOLAR LOCALIZATION SIGNALSF31GM014762 · NIGMS · BROWN UNIVERSITY · PI RIVERA-LEON, RAFAEL · 1992 to 1993
–
NIGMS NIH HHS GM 14762NIGMS NIH HHS GM 20261
6 · The paper itself

Abstract

Retention of some components within the nucleolus correlates with the presence of rRNA precursors found early in the rRNA processing pathway. Specifically, after most 40S, 38S and 36S pre-rRNAs have been depleted by incubation of Xenopus kidney cells in 0.05 microg/ml actinomycin D for 4 h, only 69% U3 small nucleolar RNA (snoRNA), 68% U14 snoRNA and 72% fibrillarin are retained in the nucleolus as compared with control cells. These nucleolar components are important for processing steps in the pathway that gives rise to 18S rRNA. In contrast, U8 snoRNA, which is used for 5.8S and 28S rRNA production, is fully retained in the nucleolus after actinomycin D treatment. Therefore, U8 snoRNA is in a different category than U3 and U14 snoRNA and fibrillarin. It is proposed that U3 and U14 snoRNA and fibrillarin, but not U8 snoRNA, bind to the external transcribed spacer or internal transcribed spacer 1, and when these binding sites are lost after actinomycin D treatment some of these components cannot be retained in the nucleolus. Other binding sites may also exist, which would explain why only some and not all of these components are lost from the nucleolus.

Indexed as

AnimalsBase SequenceCell NucleolusChromosomal Proteins, Non-HistoneDactinomycinMolecular Sequence DataNucleic Acid Synthesis InhibitorsRNA PrecursorsRNA, RibosomalRNA, Small NuclearXenopus laevisChromosomal Proteins, Non-HistoneDactinomycinfibrillarinNucleic Acid Synthesis InhibitorsRNA PrecursorsRNA, RibosomalRNA, Small Nuclear

Identifiers

PMID9211978
OpenAlexW2021988776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.